Atypical neuroleptic malignant syndrome in an adolescent

J Child Adolesc Psychopharmacol. 2008 Apr;18(2):215-20. doi: 10.1089/cap.2008.1821.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Adolescent
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Benzodiazepines / adverse effects
  • Benzodiazepines / therapeutic use
  • Chlorpromazine / adverse effects
  • Chlorpromazine / therapeutic use
  • Diagnosis, Differential
  • Dibenzothiazepines / adverse effects*
  • Dibenzothiazepines / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Injections, Intramuscular
  • Male
  • Neuroleptic Malignant Syndrome / diagnosis*
  • Olanzapine
  • Paranoid Disorders / diagnosis
  • Paranoid Disorders / drug therapy*
  • Paranoid Disorders / psychology
  • Quetiapine Fumarate

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Benzodiazepines
  • Quetiapine Fumarate
  • Olanzapine
  • Chlorpromazine